{
  "id": 2762404,
  "title": "Doctors achieve new feat in cancer treatment with cord transplant and Car T-cell therapy",
  "url": "https://urgent.news/2026/08/23/doctors-achieve-new-feat-in-cancer-treatment-with-cord-transplant-and-2762404",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-23T09:45:22.000Z",
  "source": {
    "name": "The Hindu",
    "slug": "the-hindu",
    "url": "https://www.thehindu.com/sci-tech/health/doctors-achieve-new-feat-in-cancer-treatment-with-cord-transplant-and-car-t-cell-therapy/article71380498.ece"
  },
  "original_language": "en",
  "account": "In a groundbreaking achievement in cancer treatment, doctors from Narayana Health in West Bengal successfully treated a seven-year-old boy with thalassaemia using a novel Haplo Cord transplant process. The child, diagnosed with HbE Beta thalassemia, required monthly blood transfusions. His parents underwent IVF and pre-implantation genetic testing to generate a thalassemia-free sibling with compatible HLA, making him a suitable donor. A haplo-cord transplant was performed using cord blood from the child's sibling and stem cells from his father. Despite complications such as infections, mucositis, liver dysfunction, and low blood counts, the patient has now been successfully treated and is transfusion-free.\n\nIn another significant medical breakthrough, a 62-year-old male from Myanmar suffering from brain cancer underwent CAR T-cell therapy, an advanced type of immunotherapy. Initially, the patient experienced gait disturbance and was later diagnosed with primary CNS lymphoma, a rare and aggressive form of non-Hodgkin lymphoma. After four cycles of high-dose chemotherapy failed to yield satisfactory results, the doctors opted for CAR T-cell therapy. The treatment involved lymphocyte collection, bridging with radiation and medications, and the administration of a dual CAR targeting CD19 and CD22 on the cancer cells. Dr. Joydeep Chakrabartty, Senior Consultant, Hemato Oncology & Clinical Lead - BMT Programme at Narayana Health, highlighted that both patients faced potential fatality, yet the expert team managed to transform their lives for the better. These two remarkable recoveries demonstrate Narayana Health's commitment to advancing medical science.",
  "summary": "Doctors at Narayana Health have reported two medical breakthroughs: a seven-year-old thalassaemia patient is now transfusion-free after a Haplo-cord transplant, while a 62-year-old brain cancer patient responded to dual-target CAR-T cell therapy",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu Health",
        "title": "Doctors achieve new feat in cancer treatment with cord transplant and Car T-cell therapy",
        "url": "https://urgent.news/2026/08/23/doctors-achieve-new-feat-in-cancer-treatment-with-cord-transplant-and",
        "published": "2026-08-23T09:45:22.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}